Hancornia speciosa Gomes induces hypotensive effect through inhibition of ACE and increase on NO  by Silva, G.C. et al.
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Ethnopharmacological  relevance:  The  leaves  of Hancornia  speciosa  Gomes  are  popularly  used  in  Brazil  to
treat  diabetes  and  hypertension.  Cardiovascular  diseases  are  the  main  cause  of  death  worldwide  and  their
incidences  are  increasing  in Brazilian  population.  The  present  study  aimed  to investigate  the hypotensive
effect  and  the  mechanism  of action  of  Hancornia  speciosa  Gomes.
Methods:  A  fraction  of the  ethanolic  extract of  leaves  from  Hancornia  speciosa  (SFH)  was  obtained  and
standardized  by its  content  on  rutin,  bornesitol  and  quinic  acid.  Systolic  blood  pressure  (SBP)  of  nor-
motensive  mice  was  measured  by  tail  pletismography.  SFH  was given  orally  and  SBP  was  monitored  for
5 h. Angiotensin-converting  enzyme  (ACE)  inhibitor  activity  of  SFH  (1 mg/kg)  or captopril  (10  mg/kg)  was
measured by  colorimetric  methods.  Serum  nitrite  levels  were  measured  by spectrophotometry.
Results:  SFH  induced  a dose-dependent  hypotensive  effect  in normotensive  mice. The  serum  activity  of
ACE  and  the level  of  angiotensin  II were  signiﬁcantly  reduced  by SFH  and  by  captopril.  Administration
of  SFH  induced  a signiﬁcant  increase  on  plasmatic  level  of nitrites  and  the  systemic  inhibition  of  nitric
oxide  synthase  by  L-NAME  (20  mg/kg)  reduced  the  hypotensive  effect  of  SFH.
Conclusions:  The  present  work  demonstrated  that  Hancornia  speciosa  has  a potent  hypotensive  effect  in
normotensive  mice.  The  inhibition  of  ACE  leading  to reduction  on  angiotensin  II and  increase  on  NO
levels  might  account  for the  hypotensive  effect.  These  results  support  the  use  of  Hancornia  speciosa  by
ntihy
 traditional  medicine  as  a
. Introduction
Cardiovascular diseases are the main (among the major causes)
ause of global mortality, being hypertension the most common
nd the main contributor for the pathogenesis of myocardial and
erebral infarction, and renal disorders (Lawes et al., 2008). Plants
onsumed on diet or species traditionally used with medicinal
urposes have been associated to the reduction on cardiovascular
isease (Hertog et al., 1993) and lowering of blood pressure (Faraji
nd Tarkhani, 1999). Therefore, the investigation of plants used in
raditional medicine for the treatment of hypertension may  lead to
he development of new drugs.
Hancornia speciosa Gomes (Apocynaceae), commonly known as
mangabeira”, is a plant species found in “cerrado”, a savanna-like
egetation found in Brazil. The leaves of Hancornia speciosa are
opularly used to treat diabetes and hypertension (Grandi et al.,
981; Schmeda-Hirschmann and Rojas de Arias, 1990). Recently,
∗ Corresponding author. Tel.: +55 31 3409 2726; fax: +55 31 3409 2695.
E-mail address: sfcortes@icb.ufmg.br (S.F. Cortes).
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Open access under the Elsevier OA license. pertensive.
© 2011 Elsevier Ireland Ltd. 
our group demonstrated that the ethanolic extract from leaves
of this species promotes vasorelaxant effects in rat aorta and
mesenteric arteries through endothelium production of nitric oxide
(NO) via phosphatidyl-inositol 3-kinase (PI3K) activation (Ferreira
et al., 2007a,b). Vasodilators are clinically used to treat hyperten-
sion (Mancia et al., 2007), pointing out the potential of Hancornia
speciosa as anti-hypertensive agent.
The extract of Hancornia speciosa leaves is characterized by
the presence of ﬂavonoids and cyclitols (Ferreira et al., 2007a,b;
Endringer et al., 2009). The present study was aimed at investi-
gating the hypotensive effect and the mechanism of action of a
standardized fraction of Hancornia speciosa leaves.
2. Materials and methods
2.1. Preparation of standardized fraction of Hancornia speciosa
(SFH)
Open access under the Elsevier OA license.The leaves of Hancornia speciosa were collected in São Gonc¸ alo
do Rio Preto, Minas Gerais state, Brazil, in October 2003. The plant
material was  identiﬁed by Dr. Júlio Antônio Lombardi and the
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oucher specimen BHCB 49895 is deposited at the Herbarium of the
niversidade Federal de Minas Gerais. After drying at 40 ◦C, during
2 h, the dry leaves were powdered (251.8 g) and percolated with
6% EtOH at room temperature. The solvent was removed under
educed pressure furnishing 69.1 g of a dark residue, which was  suc-
essively extracted with solvents of increasing polarity giving seven
ractions (F-1 to F-7). Yields (solvent employed for elution, % w/w)
f fractions from the crude extract: F1 (n-hexane, 1.7%), F2 (DCM,
0.4%), F3 (DCM/EtOAc 1:1, 2.5%), F4 (EtOAc, 0.7%), F5 (EtOAc/MeOH
:1, 45.5%), F6 (MeOH, 6.2%), and F7 (MeOH/water 1:1, 2.9%).
he standardized fraction F-5, containing rutin, l-(+)-bornesitol
nd quinic acid as constituents, had the highest yielding, elicited
he highest ACE inhibitory activity among the fractions and also
howed marked inhibitory effect against NF-kappa-B (Endringer,
007; Endringer et al., 2009). For the above reasons fraction F-5
as chosen for evaluation of the hypotensive effect in vivo.
.2. Animals
All experimental protocols were performed in accordance with
uidelines for the human use of laboratory animals at UFMG
nd were previously approved by the ethics committee [protocol
 227/08, Comitê de Ética em Experimentac¸ ão Animal (CETEA),
niversidade Federal de Minas Gerais (UFMG)]. Male Swiss mice
12–15 week-old) were used. All animals were obtained from Cebio
Centro de Bioterismo do Instituto de Ciências Biológicas, UFMG).
ree access was allowed to standard diet (Labina), and tap water
as supplied ad libitum. All mice were maintained at eight per cage
t a constant temperature (23 ± 2 ◦C), with a 12-h dark/light cycle.
.3. Blood pressure measurements
Systolic blood pressure (SBP) and heart rate (HR) were measured
y the tail-cuff method (Rezende et al., 2009), using a XBP1000
eries Rat Tail Blood Pressure System (Kent Scientiﬁc, Torring-
on, CT). Conscious mice were conditioned to restraint at the
arming chamber controlled at 37 ◦C at least for 5 min. After this
eriod an integrated sensor-cuff was placed and used to take at
east seven different measurements of SBP through the pressure
alue necessary to stop the heart beat registered in tail. Mea-
urements were taken every 15 or 30 min  for 5 h and recorded
sing a DI-194RS data acquisition system (Dataq, Akron, OH)
onnected to a personal computer. Therefore, it was possible to
ssemble curves representing the proﬁle of SBP and heart rate
HR) of each animal. An adaptation period of 1 week for vehicle
dministration and SBP measurements was allowed before the ini-
iation of experiments. After measurement of the basal SBP, each
nimal randomly received by intragastric gavage (p.o.) of saline,
, 10 and 100 mg/kg of SFH dissolved in saline or 10 mg/kg of
aptopril.
.4. Angiotensin converting enzyme (ACE) activity in serum
ACE inhibitory activity was determined using a method
escribed by Lucas-Filho et al. (2010),  modiﬁed to employ
ice plasma as enzyme source. Mice received 1 mg/kg SFH,
0 mg/kg captopril or saline by intragastric gavage. One hour
fter, animals were sacriﬁced by decapitation and the blood
ollected in microtubes. Blood was centrifuged at 3000 × g for
 min  and the serum was collected. 25 l aliquots of the serum
ere placed in a microtitre plate and the enzymatic reaction
as started by adding 25 l assay buffer (in mM:  50 HEPES,
00 NaCl, 400 Na2SO4, pH 8.15) and 10 l substrate solution
ip-Gly-Gly (100 M)  (Sigma, USA). After homogenization, the
ixture was incubated for 35 min, at 37 ◦C. The reaction was
topped by the addition of 30 l sodium tungstate (100 g/l) andmacology 137 (2011) 709– 713
30 l sulfuric acid (0.33 mM).  The system was  mixed with the
color reagent 2,4,6-trinitrobenzenesulfonic acid solution, TNBS
(6.92 mM)  (Sigma, USA). After 20 min, the plate absorbance was
read in a microtitre plate reader (Thermoplate reader) at 415 nm
against a blank solution similarly prepared, except by adding the
sodium tungstate and the sulfuric acid solutions before enzyme
solution.
2.5. Plasmatic angiotensin II levels
Levels of angiotensin II in the plasma were determined by
radioimmunoassay. Plasma samples containing the enzymatic
inhibitors (all at 10 mM)  ortho-phenanthroline, EDTA, dipyridyl
and sodium tetrathionate were previously diluted in 25 mM  sodium
phosphate buffer pH 7.4 (with the same inhibitors). Plasmatic
angiotensin II concentration on the samples was determined from a
standard curve established with synthetic peptide (GenScript). The
molar concentration of the standard angiotensin II was  determined
spectrophotometrically at 275 nm (ε = 1379 M−1 cm−1).
2.6. Nitrite dosage in the serum
Nitrite (NO2−) was measured using the Griess reaction with
modiﬁcations (Zocrato et al., 2010). Brieﬂy, the animals were
treated by intragastric gavage with 1 mg/kg SFH or 20 mg/kg L-
NAME or saline. One hour after, the animals were euthanized by
decapitation. An aliquot (100 l) of mice serum was added to a
microtitre plate and the enzymatic treatment was  started by adding
10 UL/ml Aspergillus nitrate reductase (Sigma, USA), 1 M HEPES
buffer (pH 7.4), 0.1 mM FAD, 1 mM NADPH. After homogeniza-
tion, the mixture was incubated for 30 min, at 37 ◦C. 1500 U/ml
lactate dehydrogenase and 100 mM pyruvic acid were then added
and mixture for 10 min  at 37 ◦C. Following the above enzymatic
treatment steps, 500 l of sample was  added to each freshly pre-
pared 500 l Griess. The absorbance of each sample was then
determined at 540 nm and total nitrite concentrations were cal-
culated from the slope of the standard curves established using
known concentrations of nitrite. The water was used as blank
solution.
2.7. Statistical analysis
Results are shown as mean ± S.E.M. Two-way ANOVA with Bon-
ferroni multiple comparisons post-test was used to compare SBP
and concentration–response curves. Student’s t-test was used to
compare nitrite and angiotensin II concentrations.
3. Results and discussion
Baseline values of mice SBP and HR were 119 ± 4 mmHg
and 610 ± 5 beats/min, respectively. SFH (1, 10 and 100 mg/kg,
p.o.) induced a dose-dependent hypotensive effect (Fig. 1A). The
hypotensive response after each dose of SFH started at 15 ± 3 min
and SBP returned to baseline after approximately 5 h. The effect
of SFH had longer duration and was  superior to the effect of the
ethanolic extract of Hancornia speciosa (data not shown). A signif-
icant increase on HR was observed only with 100 mg/kg (Fig. 1B).
Captopril at a dose 10 fold higher (10 mg/kg, p.o.) reduced mice
SBP in the same magnitude as SFH (1 mg/kg, p.o.; Fig. 2). More-
over, the duration of the effect of captopril was  smaller compared
to SFH. These results demonstrate that SFH induced a potent
and long-lasting dose-dependent hypotensive effect on mice after
administration by oral route. This observation is relevant since
SFH demonstrated an oral bioavailability good enough to induce
a hypotensive effect with fast beginning and long duration. It is
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As illustrated in Fig. 3, the plasmatic activity of ACE was signif-
icantly inhibited by SFH (1 mg/kg). Similarly, captopril (10 mg/kg)
reduced the plasmatic activity of ACE (Fig. 3). The plasmatic activ-ig. 1. Effect of increasing doses of a standardized fraction of Hancornia speciosa lea
he  heart rate in mice. All results are expressed as mean ± S.E.M. of at least ﬁve exp
f note that SHF was more potent and long lasting than cap-
opril, a well established anti-hypertensive drug used in clinic.
his effect is likely related to the compounds found in this frac-
ion, which are rutin, l-(+)-bornesitol and quinic acid (Endringer
t al., 2009). Quercetin, the aglycone of rutin, has its plasmatic
oncentration increased after oral administration of rutin in rats
Barrow and Grifﬁths, 1974), and its anti-hypertensive effect has
een reported (Duarte et al., 2001), but the duration of the effect
as not as long as observed with SFH. However, cardiovascular
ffects of quinic acid and bornesitol have not been described so
ar, and further investigations should be done to evaluate their
ffects.
The renin–angiotensin system (RAS) plays a key role in the
athophysiology and development of many cardiovascular dis-
ases, including hypertension (Weir and Dzau, 1999). Angiotensin
I, the major component of RAS, has known effects, such as, vaso-
onstriction and stimulation of cell growth, sodium and water
etention, and sympathetic activation (for review see: Hoogwerf,
010). There are many experimental evidences suggesting that
ngiotensin II is able to induce endothelial dysfunction, inﬂam-
atory responses, oxidative stress, insulin resistance, and to
educe -cell responsiveness (Negro, 2008). The close relationship
etween RAS and hypertension has led to compelling indications
ig. 2. Comparison on the effect of a standardized fraction of Hancornia speciosa
eaves (SFH; 1 mg/kg) and captopril (10 mg/kg), administered by oral route, on the
ystolic blood pressure (SBP) of mice. All results are expressed as mean ± S.E.M. of
t least ﬁve experiments. *P < 0.05 versus saline values.FH), administered by oral route, on (A) the systolic blood pressure (SBP) and on (B)
nts. *P < 0.05, **P < 0.01 SFH doses versus saline values.
to block the formation or activity of angiotensin II through use of
inhibitors of ACE (iACE) and angiotensin receptor blockers to treat
hypertension (Mancia et al., 2007).Fig. 3. Effect of a standardized fraction of Hancornia speciosa leaves (SFH; 1 mg/kg)
and  captopril (10 mg/kg), administered by oral route, on the plasmatic activity of
angiotensin converting enzyme (ACE). All results are expressed as mean ± S.E.M. of
at  least ﬁve experiments. ***P < 0.001 versus saline values.
Fig. 4. Effect of a standardized fraction of Hancornia speciosa leaves (SFH; 1 mg/kg)
and  captopril (10 mg/kg), administered by oral route, on mice plasmatic level of
angiotensin II. All results are expressed as mean ± S.E.M. of at least ﬁve experiments.
***P  < 0.001 versus saline values. †††P < 0.001 versus values of captopril at 1 h.
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Hig. 5. Effect of a standardized fraction of Hancornia speciosa leaves (SFH; 1 mg/kg), 
lood  pressure (SBP; B), and the inhibitory effect of L-NAME (20 mg/kg; ip) on the a
t  least ﬁve experiments. **P < 0.01 and ***P < 0.001 versus control values. ††P < 0.01
ty of ACE from mice was strongly inhibited at least up to 1 h after
ral administration of SFH. This effect was similar to that observed
ith captopril. The inhibitory effect of SFH on plasmatic activity
f ACE is in line to previous reported in vitro inhibition ACE effect
f the crude ethanolic extract of Hancornia speciosa leaves and it
an contribute to the hypotensive effect of this plant (Serra et al.,
005).
Oral administration of SFH (1 mg/kg) reduced by 56.6 ± 2.7% the
lasmatic level of angiotensin II, when compared to saline-treated
ice (Fig. 4). This effect lasted at least 2 h after administration
f SFH. Captopril also reduced the plasmatic level of angiotensin
I, but its effect lasted only 1 h (Fig. 4). Two hours after captopril
dministration, the level of angiotensin II was similar to that before
reatment (Fig. 4). This observation can be attributed to the short
lasmatic half-life of captopril (Pereira et al., 1996). Importantly,
he reduction on the level of angiotensin II may  also contribute to
n indirect vasorelaxant effect of this fraction and, consequently, to
educe peripheral vascular resistance. In addition, this observation
lso suggests that the use of SFH might contribute to reduction on
ascular and cardiac remodeling, as observed for other inhibitors
f ACE (Kiowski et al., 1991).
NO plays an important role in the cardiovascular system. It mod-
lates vascular tone, decreases platelet adhesion and aggregation,
nd inhibits growth of vascular smooth muscle cells (Moncada
t al., 1991; Scott-Burden and Vanhoutte, 1994). Impairment of
O production by vascular endothelial cells is associated with vas-
ular dysfunction, which is known to be an important factor in
athologies, such as atherosclerosis, restenosis, hypertension and
schemic events in coronary and cerebral vascular bed (Luscher,
994; Shimokawa and Tsutsui, 2010). In the present study, SFH
1.0 mg/kg), administered by oral route, induced a signiﬁcant
ncrease on plasmatic content of nitrite (Fig. 5A). Pre-treatment
f mice with L-NAME (20 mg/kg, p.o.) blunted the effect of SFH
Fig. 5A). The relevance of this effect was conﬁrmed by the
nhibitory effect of L-NAME on the hypotensive effect of SFH
1.0 mg/kg; Fig. 5B). The augmented production of NO can be an
mportant mechanism for the hypotensive effect of SFH, as in mice
retreated with L-NAME both plasmatic levels of nitrite and reduc-
ion on SBP were strongly inhibited. Since NO has a protective
ffect against damages caused by high blood pressure (Moncada
t al., 1991; Wollny et al., 1999) and that hypertensive subjects
ave an impaired production of NO (Linder et al., 1990), a drug able
o increase the production of this autacoid can be useful on pre-
ention of further complications on cardiovascular system during
ypertension.. Conclusions
The present work demonstrated that a standardized fraction of
ancornia speciosa leaves reduced the mice systolic blood pressureistered by oral route, on (A) the plasmatic level of nitrite (NO2−) and on (B) systolic
 SFH in normotensive mice (A and B). All results are expressed as mean ± S.E.M. of
†P < 0.001 versus values of SFH alone.
through inhibition of plasmatic ACE activity, reduction of plas-
matic angiotensin II level and increasing the plasmatic level of NO.
Therefore, these results support the use of Hancornia speciosa by
traditional medicine as antihypertensive.
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